To have your event listed in our calendar, please fill out an event form. A basic entry (left of form) is entirely free of charge.
To have your event ’featured’ (also complete the right part of form) there is a charge of £200 + VAT.
For a further £300 + VAT your featured event will be included in our weekly newsletter.
Please fill in the featured event section and we will contact you to discuss your requirments.
BIT Life Sciences and Organizing Committee are organizing the 2nd World Cancer Congress as part of their dedication to offer professionals in cancer filed a multidisciplinary platform to learn about the latest scientific updates and current industry standards in cancer treatment. The congress with the theme “The Gateway to Future Medicine” will be held during June 22-25, 2009, Beijing, China. [More]
The Europe shows October 2009:
ICSE: The International Contract Services Expo (www.icsexpo.com)
BioPh: Bio-solutions for Pharma (www.bioph-online.com)
P-MEC: The Pharmaceutical Machinery and Equipment Convention (www.p-mec.com)
CPhI: The Convention on Pharmaceutical Ingredients. (www.cphi.com)
[More]
SMi’s leading Clinical Trials in Cancer conference provides the latest thinking in adaptive trial designs, insight into cancer biomarkers, the challenges of translational medicine and case studies on the logistical and operational issues with conducting clinical trials in Europe. [More]
The significant amount of change in the pharmaceutical and biopharmaceutical industry commands the development of fundamentally new approaches to meet the growing needs for drug safety and efficacy more quickly and efficiently. The Evolution Summit addresses the critical challenges of drug development professionals to speed new products to market and constantly stay ahead of the latest decision-making, operational and technology trends. [More]
BIT Life Sciences’ World Summit Antivirals (WSA) is a focused event for updating the current advances in worldwide R & D of Novel Antiviral Therapeutics. The anticipated attendees will represent top-level decision makers from leading biotech, pharmaceutical and healthcare organizations. [More]